AMAG PHARMACEUTICALS INC's ticker is and the CUSIP is 00163UAA4. A total of 21 filers reported holding AMAG PHARMACEUTICALS INC in Q4 2014. The put-call ratio across all filers is - and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $5,265,000 | +24.9% | 3,721,000 | 0.0% | 0.50% | +16.5% |
| Q3 2016 | $4,215,000 | +2.3% | 3,721,000 | 0.0% | 0.43% | +26.8% |
| Q2 2016 | $4,122,000 | -81.7% | 3,721,000 | -82.0% | 0.34% | -81.1% |
| Q1 2016 | $22,487,000 | -14.0% | 20,721,000 | 0.0% | 1.80% | -10.2% |
| Q4 2015 | $26,144,000 | -21.7% | 20,721,000 | 0.0% | 2.01% | -24.6% |
| Q3 2015 | $33,369,000 | -37.7% | 20,721,000 | 0.0% | 2.66% | -15.9% |
| Q2 2015 | $53,587,000 | +77.8% | 20,721,000 | +42.9% | 3.17% | +107.2% |
| Q1 2015 | $30,140,000 | +94.9% | 14,505,000 | +56.8% | 1.53% | +106.2% |
| Q4 2014 | $15,461,000 | +24.7% | 9,250,000 | 0.0% | 0.74% | +2.5% |
| Q3 2014 | $12,394,000 | +26.2% | 9,250,000 | 0.0% | 0.72% | +16.2% |
| Q2 2014 | $9,824,000 | +43.0% | 9,250,000 | +37.0% | 0.62% | +74.7% |
| Q1 2014 | $6,872,000 | – | 6,750,000 | – | 0.36% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Birch Grove Capital LP | 17,250,000 | $19,597,000 | 18.38% |
| STEELHEAD PARTNERS LLC | 17,000,000 | $19,264,000 | 1.88% |
| Bruce & Co., Inc. | 5,500,000 | $6,600,000 | 1.78% |
| STELLIAM INVESTMENT MANAGEMENT, LP | 26,750,000 | $30,177,000 | 1.01% |
| Castle Creek Arbitrage, LLC | 3,721,000 | $4,215,000 | 0.43% |
| LINDEN ADVISORS LP | 7,000,000 | $7,909,000 | 0.36% |
| Sonora Investment Management, LLC | 1,510,000 | $1,702,676,000 | 0.36% |
| BASSO CAPITAL MANAGEMENT, L.P. | 2,110,000 | $2,382,000 | 0.35% |
| WOLVERINE ASSET MANAGEMENT LLC | 18,400,000 | $20,808,000 | 0.31% |
| SSI INVESTMENT MANAGEMENT LLC | 1,975,000 | $2,221,000 | 0.20% |